FSHR inactivating mutations cause primary or secondary amenorrhea, infertility, and premature ovarian failure (POF), whereas activating mutations can predispose to ovarian hyperstimulation syndrome (OHSS). This evidence concerns the gene FSHR and ovarian hyperstimulation syndrome.